The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCSL.L Regulatory News (CCSL)

  • There is currently no data for CCSL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Primary Investment

6 Jan 2016 07:00

RNS Number : 9345K
Chenavari Capital Solutions Limited
06 January 2016
 



6 January 2016

Chenavari Capital Solutions Limited

Primary Investment

 

Chenavari Capital Solutions Limited (the "Company") has invested €4mn in junior instruments in a short term loan warehousing transaction backed by a portfolio of leveraged corporate loans. Senior finance was provided by a leading global bank and financial services firm (the Bank).

 

The portfolio provides exposure to primarily European and UK corporates with ratings at or higher than B-. The portfolio is diversified with an expected maximum concentration of 4% by group of borrowers. The junior instruments represent first loss risk and the Company expects the thickness of the tranche (approximately 20%) to provide a resilient feature.

 

Upon acquisition, the transaction represented approximately 3% of the Company's net asset value. Following the above transaction and other cash flows the Company is now approximately 94% invested.

 

The expected return of the investment is in excess of Company's target gross return1. Chenavari Investment Managers, the Investment Advisor of the Company, continues to work on a pipeline of originated transactions with attractive risk-adjusted returns.

 

1 Hypothetical performance forecasts have many inherent limitations, some of which are described below. No representation is being made that the investment or the Company will or is likely to achieve profits similar to those shown. In fact, there are frequently sharp differences between hypothetical performance forecasts and the actual results subsequently achieved by any particular investment. One of the limitations of hypothetical performance forecasts is that they are generally prepared with the benefit of hindsight and do not involve financial risk in actual trading. The achievement of hypothetical performance forecasts can be affected by changes in specific trading programs, economic conditions, foreign exchange rates, interest rates and/or credit spreads, impairments, and other external factors, including those resulting from war, incidents of terrorism or responses to such events.

 

About CCSL

Chenavari Capital Solutions Limited, incorporated in Guernsey, is a closed-ended investment company admitted to trading on the specialist fund market of the London Stock Exchange on 7 October 2013. The Investment Objective of the Company is to provide Shareholders with an attractive return, while limiting downside risk, through investment in Bank Capital Solutions Transactions primarily with UK and European banks. Bank Capital Solutions Transactions are transactions designed to allow banks to reduce their risk-weighted assets on portfolios of assets, or otherwise optimise the capital required to be held against such exposures. The Company seeks to exploit opportunities arising from the increased regulatory capital requirements for European banks under the Basel III framework. The strategy allows banks to reduce the regulatory capital required to be held against specific portfolios of assets.

 

Forward-looking statements

This announcement contains forward-looking statements including, without limitation, statements containing the words "believes", "estimates", "anticipates", "expects", "intends", "may", "will", "target" or "should" or, in each case, their negative or other variation or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, financial condition, performance or achievement of the Company or any Originator, or industry results, to be materially different from future results, financial condition, performance or achievements expressed or implied by such forward-looking statements. Past performance is not a reliable indicator of future performance and the Company may not achieve the same level of returns as those achieved by previous investments. Target returns are estimated only and net of fees, expenses and income reinvested. They are based on long-term performance projections of the investment strategy and market conditions at the time of modelling and therefore, subject to change. There is no guarantee that any target returns can be achieved. Investors should not place reliance on such target returns in deciding whether to invest in the Company.

 

About Chenavari

Chenavari Investment Managers is the trading name of Chenavari Credit Partners LLP and is part of the Chenavari Financial Group, a specialist alternative asset management group focusing on European & Asian markets. With over 100 professionals and USD5.4 billion of assets under management2, funds managed by Chenavari target investment strategies across Credit (Corporate and High yield, Financials, Credit Derivatives), Structured Finance (ABS, CMBS, Regulatory Capital) and Illiquid Opportunities (Private Debt, Real Estate, Consumer Finance, Private Equity). The Chenavari group contains entities authorized and regulated by several regulators globally, including the UK FCA, the Luxembourg CSSF, the US SEC, the US CFTC and the Hong Kong SFC. (www.chenavari.com)

 

2 Includes committed but undrawn capital of approximately US$200mn, full amount available with 7 days' notice, payable within 10 business days after notice

 

Enquiries:

 

Kirstie McLaren

Chenavari Investment Managers

Email: clir@chenavari.com

Telephone: +44 20 7259 3600

 

Robert Peel

Dexion Capital plc

Telephone: +44 20 7832 0900

 

 

IMPORTANT INFORMATION

This document has been issued by Chenavari Capital Solutions Limited, and should not be taken as an inducement to engage in any investment activity and is for the purpose of providing information about the Company. This document does not constitute or form part of, and should not be construed as, any offer for sale or subscription of, or solicitation of any offer to buy or subscribe for, any share in the Company or securities in any other entity, in any jurisdiction, including the United States, Canada, Japan, South Africa nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with, any contract or investment decision whatsoever, in any jurisdiction.

This document, and the information contained therein, is not for viewing, release, distribution or publication in or into the United States, Canada, Japan, South Africa or any other jurisdiction where applicable laws prohibit its release, distribution or publication, and will not be made available to any national, resident or citizen of the United States, Canada, Japan or South Africa. The distribution of this document in other jurisdictions may be restricted by law and persons into whose possession this document comes must inform themselves about, and observe, any such restrictions. Any failure to comply with the restrictions may constitute a violation of the federal securities law of the United States and the laws of other jurisdictions.

The shares issued and to be issued by the Company (the "Shares") have not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act"), or with any securities regulatory authority of any state or other jurisdiction of the United States. The Shares may not be offered, sold, resold, pledged, delivered, distributed or otherwise transferred, directly or indirectly, into or within the United States, or to, or for the account or benefit of, US persons (as defined in Regulation S under the Securities Act). No public offering of the Shares is being made in the United States.

The Company has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act") and, as such, holders of the Shares will not be entitled to the benefits of the Investment Company Act. No offer, sale, resale, pledge, delivery, distribution or transfer of the Shares may be made except under circumstances that will not result in the Company being required to register as an investment company under the Investment Company Act. Neither the U.S. Securities and Exchange Commission (the "SEC") nor any state securities commission has approved or disapproved of the Shares or passed upon or endorsed the merits of the offering of the Shares or the adequacy or accuracy of the Company's prospectus. Any representation to the contrary is a criminal offence in the United States. In addition, the Shares are subject to restrictions on transferability and resale in certain jurisdictions and may not be transferred or resold except as permitted under applicable securities laws and regulations. Investors may be required to bear the financial risks of their investment in the Shares for an indefinite period of time. Any failure to comply with these restrictions may constitute a violation of the securities laws of any such jurisdictions.

No liability whatsoever (whether in negligence or otherwise) arising directly or indirectly from the use of this document is accepted and no representation, warranty or undertaking, express or implied, is or will be made by the Company, or any of their respective directors, officers, employees, advisers, representatives or other agents ("Agents") for any information or any of the opinions contained herein or for any errors, omissions or misstatements. None of the Agents makes or has been authorised to make any representation or warranties (express or implied) in relation to the Company or as to the truth, accuracy or completeness of this document, or any other written or oral statement provided. In particular, no representation or warranty is given as to the achievement or reasonableness of, and no reliance should be placed on any, targets, estimates or forecasts contained in this document and nothing in this document is or should be relied on as a promise or representation as to the future.

Unless otherwise indicated, the information provided herein is based on matters as they exist as of the date of preparation and not as of any future date.

All investments are subject to risk, including the loss of the principal amount invested. Past performance is no guarantee of future returns. All investments to be held by the Company involve a substantial degree of risk, including the risk of total loss. The value of shares and the income from them is not guaranteed and can fall as well as rise due to stock market and currency movements. When you sell your investment you may get back less than you originally invested. You should always seek expert legal, financial, tax and other professional advice before making any investment decision.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCDELFBQFFXBBD
Date   Source Headline
30th Sep 20203:00 pmRNSResult of EGM
30th Sep 20201:00 pmRNSFactsheet Available - August 2020
24th Sep 20205:00 pmRNSNet Asset Value(s)
11th Sep 20207:00 amRNSHolding(s) in Company
10th Sep 202011:00 amRNSFactsheet Available - July 2020
10th Sep 20207:00 amRNSHolding(s) in Company
4th Sep 20202:00 pmRNSNotice of EGM
28th Aug 20207:00 amRNSCancellation Admission to Trading - Notice of EGM
25th Aug 20204:00 pmRNSNet Asset Value(s)
24th Jul 202011:15 amRNSNet Asset Value(s)
14th Jul 20207:00 amRNSPartial Compulsory Redemption of Shares
29th Jun 20202:15 pmRNSFactsheet Available - May 2020
26th Jun 20203:00 pmRNSPartial Compulsory Redemption of Shares
24th Jun 20204:00 pmRNSNet Asset Value(s)
9th Jun 202010:15 amRNSFactsheet Available - April 2020
1st Jun 20207:00 amRNSNet Asset Value(s)
4th May 20208:31 amRNSFactsheet Available - March 2020
27th Apr 20203:30 pmRNSNet Asset Value(s) and Dividend
17th Apr 202010:30 amRNSResult of AGM
8th Apr 20202:00 pmRNSFactsheet Available - February 2020
2nd Apr 20207:00 amRNSAGM Adjournment
1st Apr 20204:00 pmRNSChange of Name of Administrator/Company Secretary
23rd Mar 20204:30 pmRNSNet Asset Value(s)
20th Mar 20207:00 amRNSPartial Compulsory Redemption of Shares
18th Mar 202012:30 pmRNSUPDATED Partial Compulsory Redemption of Shares
4th Mar 202010:00 amRNSFactsheet Available - January 2020
2nd Mar 20207:00 amRNSPartial Compulsory Redemption of Shares
27th Feb 202011:30 amRNSNet Asset Value(s)
4th Feb 202012:15 pmRNSFactsheet Available - December 2019
22nd Jan 20205:45 pmRNSReplacement - Annual Financial Report
22nd Jan 20205:00 pmRNSAnnual Financial Report
21st Jan 20203:00 pmRNSDividend Declaration
21st Jan 20202:30 pmRNSNet Asset Value(s)
7th Jan 20202:00 pmRNSFactsheet Available - November 2019
30th Dec 20193:00 pmRNSHolding(s) in Company
30th Dec 20193:00 pmRNSHolding(s) in Company
23rd Dec 20194:30 pmRNSNet Asset Value(s)
23rd Dec 201911:00 amRNSHolding(s) in Company
10th Dec 20197:00 amRNSPartial Compulsory Redemption of Shares
6th Dec 20192:00 pmRNSFactsheet Available - October 2019
26th Nov 20195:15 pmRNSPartial Compulsory Redemption of Shares
22nd Nov 20192:30 pmRNSNet Asset Value(s)
30th Oct 20194:00 pmRNSFactsheet Available - September 2019
24th Oct 20193:00 pmRNSDividend Declaration
23rd Oct 201910:30 amRNSNet Asset Value(s)
8th Oct 20197:00 amRNSPartial Compulsory Redemption of Shares
3rd Oct 20194:45 pmRNSFactsheet Available - August 2019
26th Sep 20195:30 pmRNSPartial Compulsory Redemption of Shares
25th Sep 20195:40 pmRNSNet Asset Value(s)
25th Sep 201911:30 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.